| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |